Janos Nadas, Ph.D. - Publications

2009 Chemistry Ohio State University, Columbus, Columbus, OH 
Biochemistry, Cell Biology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Roh E, Lee MH, Zykova TA, Zhu F, Nadas J, Kim HG, Bae KB, Li Y, Cho YY, Curiel-Lewandrowski C, Einspahr J, Dickinson SE, Bode AM, Dong Z. Targeting PRPK and TOPK for skin cancer prevention and therapy. Oncogene. PMID 29904102 DOI: 10.1038/s41388-018-0350-9  0.4
2018 Zykova T, Zhu F, Wang L, Li H, Lim DY, Yao K, Roh E, Yoon SP, Kim HG, Bae KB, Wen W, Shin SH, Nadas J, Li Y, Ma W, et al. Targeting PRPK Function Blocks Colon Cancer Metastasis. Molecular Cancer Therapeutics. PMID 29483219 DOI: 10.1158/1535-7163.MCT-17-0628  0.4
2016 Choi JE, Kim JH, Song NY, Suh J, Kim DH, Kim SJ, Na HK, Nadas J, Dong Z, Cha YN, Surh YJ. 15-Deoxy-Δ(12,14)-prostaglandin J2 stabilizes hypoxia inducible factor-1α through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2. Free Radical Research. 1-13. PMID 27598034 DOI: 10.1080/10715762.2016.1219352  0.56
2012 Li X, Li H, Li S, Zhu F, Kim DJ, Xie H, Li Y, Nadas J, Oi N, Zykova TA, Yu DH, Lee MH, Kim MO, Wang L, Ma W, et al. Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B. Carcinogenesis. 33: 2548-57. PMID 22962305 DOI: 10.1093/carcin/bgs283  0.56
2012 Chen H, Yao K, Nadas J, Bode AM, Malakhova M, Oi N, Li H, Lubet RA, Dong Z. Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods. Plos One. 7: e38261. PMID 22693608 DOI: 10.1371/journal.pone.0038261  0.56
2012 Kim MO, Kim SH, Cho YY, Nadas J, Jeong CH, Yao K, Kim DJ, Yu DH, Keum YS, Lee KY, Huang Z, Bode AM, Dong Z. ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4. Nature Structural & Molecular Biology. 19: 283-90. PMID 22307056 DOI: 10.1038/nsmb.2217  0.56
2011 Kim DJ, Reddy K, Kim MO, Li Y, Nadas J, Cho YY, Kim JE, Shim JH, Song NR, Carper A, Lubet RA, Bode AM, Dong Z. (3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivo. Cancer Prevention Research (Philadelphia, Pa.). 4: 1842-51. PMID 21885813 DOI: 10.1158/1940-6207.CAPR-11-0158  0.56
2011 Zhang W, Xia C, Nadas J, Chen W, Gu L, Wang PG. Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production. Bioorganic & Medicinal Chemistry. 19: 2767-76. PMID 21439833 DOI: 10.1016/j.bmc.2010.11.061  0.56
2011 Liu K, Cho YY, Yao K, Nadas J, Kim DJ, Cho EJ, Lee MH, Pugliese A, Zhang J, Bode AM, Dong Z, Dong Z. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. The Journal of Biological Chemistry. 286: 2057-66. PMID 21098035 DOI: 10.1074/jbc.M110.147306  0.56
2010 Oi N, Jeong CH, Nadas J, Cho YY, Pugliese A, Bode AM, Dong Z. Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase. Cancer Research. 70: 9755-64. PMID 20952510 DOI: 10.1158/0008-5472.CAN-10-2858  0.56
2009 Xia C, Zhang W, Zhang Y, Chen W, Nadas J, Severin R, Woodward R, Wang B, Wang X, Kronenberg M, Wang PG. The roles of 3' and 4' hydroxy groups in alpha-galactosylceramide stimulation of invariant natural killer T cells. Chemmedchem. 4: 1810-5. PMID 19780098 DOI: 10.1002/cmdc.200900350  0.56
2009 Nadas J, Li C, Wang PG. Computational structure activity relationship studies on the CD1d/glycolipid/TCR complex using AMBER and AUTODOCK. Journal of Chemical Information and Modeling. 49: 410-23. PMID 19434842 DOI: 10.1021/ci8002705  0.56
2007 Chen W, Xia C, Wang J, Thapa P, Li Y, Talukdar A, Nadas J, Zhang W, Zhou D, Wang PG. Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues. The Journal of Organic Chemistry. 72: 9914-23. PMID 18020363 DOI: 10.1021/jo701539k  0.56
2007 Lu D, Nadas J, Zhang G, Johnson W, Zweier JL, Cardounel AJ, Villamena FA, Wang PG. 4-Aryl-1,3,2-oxathiazolylium-5-olates as pH-controlled NO-donors: the next generation of S-nitrosothiols. Journal of the American Chemical Society. 129: 5503-14. PMID 17419627 DOI: 10.1021/ja0682226  0.56
2007 Battisti RF, Zhong Y, Fang L, Gibbs S, Shen J, Nadas J, Zhang G, Sun D. Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance. Molecular Pharmaceutics. 4: 140-53. PMID 17274671 DOI: 10.1021/mp060075v  0.56
2006 Nadas J, Sun D. Anthracyclines as effective anticancer drugs. Expert Opinion On Drug Discovery. 1: 549-68. PMID 23506066 DOI: 10.1517/17460441.1.6.549  0.56
2006 Fang L, Zhang G, Li C, Zheng X, Zhu L, Xiao JJ, Szakacs G, Nadas J, Chan KK, Wang PG, Sun D. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. Journal of Medicinal Chemistry. 49: 932-41. PMID 16451059 DOI: 10.1021/jm050800q  0.56
2004 Pan Y, Ayani T, Nadas J, Wen S, Guo Z. Accessibility of N-acyl-D-mannosamines to N-acetyl-D-neuraminic acid aldolase. Carbohydrate Research. 339: 2091-100. PMID 15280054 DOI: 10.1016/j.carres.2004.05.028  0.56
Show low-probability matches.